COMPARE · Data as of August 21, 2026

PRVA vs WAY

Verdict: Side-by-side breakdown using the Bull Rankings model. PRVA scored 56.3, WAY scored 52.9 — PRVA leads.
Compare another set
PRVA
Privia Health Group, Inc.
Health Information Services · Quality-Growth
56.3
$21.12 · $2.7B
fundamentals as of
Score gap
3.4
PRVA leads
WAY
Waystar Holding Corp.
Health Information Services · Quality-Growth
52.9
$25.01 · $4.8B
fundamentals as of
  • CheapestWAY35.7x
  • Fastest growthPRVA+24.1%
  • Strongest balance sheetPRVA0.01
  • Highest qualityWAY47 / 100
  • Largest discount to fair valuePRVA-14%
THE BULL RANKINGS SCORECARD56.3/ 100 · BULL SCOREPEER MEDIANQUALITY44.6GROWTH91.1VALUE44.0
THE BULL RANKINGS SCORECARD52.9/ 100 · BULL SCOREPEER MEDIANQUALITY47.4GROWTH87.7VALUE35.5
PRVAWAYQuality44.647.4Growth91.187.7Value44.035.5
cheap & fastrevenue growth →← cheaper (lower multiple)9%29%+31x41x+off-scalePRVAWAY

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFPRVA$131mWAY$246m
RevPRVA+24.1%WAY+19.2%
D/EPRVA0.01WAY0.37
P/EPRVA96.0xWAY35.7x
PEGPRVA4.50WAY2.85
PRVA
stronger →← stronger
WAY
45
Qualityreturns · margins · balance sheet
47
91
Growthrevenue & earnings expansion
88
44
Valuevaluation vs sector peers
35
PRVA is stronger on 2 of 3 pillars.
PRVA
WAY
$131mC
FCF
$246mC
+24.1%A-
Rev
+19.2%B+
0.01A
D/E
0.37B
96.0xD
P/E
35.7xC+
4.50D
PEG
2.85C
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
PRVA
WAY
14% below
Price vs fair valuelower is cheaper
7% above
~9%/yr
Growth the price implies10-yr FCF · lower = less priced in
~10%/yr
-8%
1-yr DCF upside
-17%
+16%
5-yr DCF upside
-7%
+63%
10-yr DCF upside
+11%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
PRVA
Why this score
  • Diluting shareholders
WAY
Why this score
  • Diluting shareholders
  • Short track record
PRVAPrivia Health Group, Inc.
Health Information Services · $21.12 · beta 0.90
Why now
Health Information Services · market cap $2.7b. Down 27% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.67 (implying +50% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 96.0x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
WAYWaystar Holding Corp.
Health Information Services · $25.01 · beta 0.06
Why now
Health Information Services · market cap $4.8b. Down 40% from 52-week high of $41.47 — deep drawdown territory. Revenue growing +19%, comfortably above the S&P median. 23 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $33.17 (implying +33% upside).
Moat
FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 40% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 36x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 3% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where PRVA and WAY diverge

On the headline score the gap is 3.4 points in favor of PRVA. The widest single difference is Value, where PRVA leads by 8.5 points.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.